Abstract:Background The disease burden from ischaemic heart disease remains heavy in the Chinese population. Traditional risk scores for estimating long-term mortality in patients with acute myocardial infarction (AMI) have been developed without sufficiently considering advances in interventional procedures and medication. The goal of this study was to develop a risk score comprising clinical parameters and intervention advances at hospital admission to assess 5-year mortality in AMI patients in a Chinese population. Methods We performed a retrospective observational study on 2,722 AMI patients between January 2013 and December 2017. Of these patients, 1,471 patients from Changsha city, Hunan Province, China were assigned to the development cohort, and 1,251 patients from Xiangtan city, Hunan Province, China, were assigned to the validation cohort. Forty-five candidate variables assessed at admission were screened using least absolute shrinkage and selection operator, stepwise backward regression, and Cox regression methods to construct the C2ABS2-GLPK score, which was graded and stratified using a nomogram and X-tile. The score was internally and externally validated. The C-statistic and Hosmer-Lemeshow test were used to assess discrimination and calibration, respectively. Results From the 45 candidate variables obtained at admission, 10 potential predictors, namely, including C reatinine, experience of C ardiac arrest, A ge, N-terminal Pro- B rain Natriuretic Peptide, a history of S troke, S tatins therapy, fasting blood G lucose, L eft ventricular end-diastolic diameter, P ercutaneous coronary intervention and K illip classification were identified as having a close association with 5-year mortality in patients with AMI and collectively termed the C2ABS2-GLPK score. The score had good discrimination (C-statistic = 0.811, 95% confidence intervals (CI) [0.786–0.836]) and calibration (calibration slope = 0.988) in the development cohort. In the external validation cohort, the score performed well in both discrimination (C-statistic = 0.787, 95% CI [0.756–0.818]) and calibration (calibration slope = 0.976). The patients were stratified into low- (≤148), medium- (149 to 218) and high-risk (≥219) categories according to the C2ABS2-GLPK score. The predictive performance of the score was also validated in all subpopulations of both cohorts. Conclusion The C2ABS2-GLPK score is a Chinese population-based risk assessment tool to predict 5-year mortality in AMI patients based on 10 variables that are routinely assessed at admission. This score can assist physicians in stratifying high-risk patients and optimizing emergency medical interventions to improve long-term survival in patients with AMI.

Development of a Risk Score for Predicting One-Year Mortality in Patients with Atrial Fibrillation Using XGBoost-assisted Feature Selection.

Validation of the Meta-Analysis Global Group in Chronic Heart Failure Risk Score for the Prediction of 1-Year Mortality in a Chinese Cohort

A machine learning-based predictive model for the in-hospital mortality of critically ill patients with atrial fibrillation

Prognostic Machine Learning Models for First-Year Mortality in Incident Hemodialysis Patients: Development and Validation Study.

Machine learning-based in-hospital mortality risk prediction tool for intensive care unit patients with heart failure

Machine Learning for the Prediction of First-Year Mortality in Incident Hemodialysis Patients

Improving Cardiovascular Risk Prediction Through Machine Learning Modelling of Irregularly Repeated Electronic Health Records

Predicting the risk of 1-year mortality among patients hospitalized for acute heart failure in China

A machine learning algorithm-based risk prediction score for in-hospital/30-day mortality after adult cardiac surgery

Simple scores to predict 1-year mortality in atrial fibrillation

Machine Learning to Predict the 1-Year Mortality Rate after Acute Anterior Myocardial Infarction in Chinese Patients

Development and validation of a novel risk score to predict 5-year mortality in patients with acute myocardial infarction in China: a retrospective study

Development and Validation of a Risk Score for Predicting 1-Year Mortality Risk of STEMI Based on a Nationwide Cohort in China

A Simple Clinical Risk Score to Predict Post-Discharge Mortality in Chinese Patients Hospitalized with Heart Failure

Improvement of APACHE II score system for disease severity based on XGBoost algorithm

Machine learning models to predict 30-day mortality for critical patients with myocardial infarction: a retrospective analysis from MIMIC-IV database

A LASSO-derived risk model for long-term mortality in Chinese patients with acute coronary syndrome

Prediction model of in-hospital mortality in intensive care unit patients with heart failure: machine learning-based, retrospective analysis of the MIMIC-III database

Optimizing Mortality Prediction for ICU Heart Failure Patients: Leveraging XGBoost and Advanced Machine Learning with the MIMIC-III Database

Development of a Multidimensional 1-Year Mortality Prediction Model for Patients Discharged from the Geriatric Department: A Longitudinal Cohort Study Based on Comprehensive Geriatric Assessment and Clinical Data

A machine learning-based risk stratification tool for in-hospital mortality of intensive care unit patients with heart failure